{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/tuberculosis/background-information/prevalence/","result":{"pageContext":{"chapter":{"id":"2deaf55e-4677-569a-a2e0-a8748b44829f","slug":"prevalence","fullItemName":"Prevalence","depth":2,"htmlHeader":"<!-- begin field debd0ddb-ac0d-4497-8448-e2120f37523b --><h2>How common is it?</h2><!-- end field debd0ddb-ac0d-4497-8448-e2120f37523b -->","summary":"","htmlStringContent":"<!-- begin item 9fcd61dc-2f50-408d-8e1a-2b690c72c19a --><!-- begin field 9745dcb6-a61a-4eef-96ba-ed0239427f7d --><p><strong>The reported prevalence of tuberculosis (TB) is complicated by a 'detection gap' of undiagnosed or unreported cases worldwide.</strong></p><ul><li><strong>The World Health Organization (WHO) continues to state there is a global TB epidemic </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">WHO, 2018b</a>]<strong>:</strong><ul><li>An estimated 10 million people (range 9.0–11.1 million) developed TB disease in 2017, however only 6.4 million (64%) cases were notified and reported to the WHO. Overall, 90% were adults (aged 15 years or more), and 9% were people with HIV.</li><li>About 1.7 billion people (23% of the world’s population) are estimated to have a latent TB infection, and are at risk of developing active TB disease during their lifetime.</li></ul></li><li><strong>Between 2000 and 2011, there was an increase in the number of cases notified and rate of TB in the UK. Since 2012, there has been an annual decline in the number of cases per year of between 2.3 and 11.5%</strong> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">PHE, 2018b</a>]<strong>.</strong><ul><li>In 2017, there were 5567 case notifications in the UK (an incidence rate of 8.4 per 100,000 people), which is the lowest number and rate recorded since surveillance data was first available in 2000 [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">PHE, 2018b</a>].<ul><li>The rate in the non UK-born population is 13 times higher than in the UK-born population, and 71% of all cases notified in 2017 were born outside the UK [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">PHE, 2018a</a>].</li><li>The decline in TB cases is likely to be due to improved TB control, a reduction of transmission in the UK, and decreases in the numbers of migrants from high TB burden countries [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">PHE, 2018a</a>].</li><li>The main burden of disease in England remains concentrated in large urban areas, with 40% of TB cases being reported in London. In 2015, London had an incidence rate of 26.2 cases per 100,000 people, resulting in one of the highest rates of TB in a capital city in western Europe [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">PHE, 2016</a>].</li><li>The number of cases of confirmed multidrug-resistant or rifampicin-resistant TB at the point of diagnosis in England decreased between 2016 and 2017, however the proportion of all TB cases notified was similar between the years (1.7% versus 1.8%). Only three of these cases had confirmed initial extensively drug-resistant TB, which is fewer than each of the previous two years' data [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">PHE, 2018a</a>].</li></ul></li></ul></li></ul><!-- end field 9745dcb6-a61a-4eef-96ba-ed0239427f7d --><!-- end item 9fcd61dc-2f50-408d-8e1a-2b690c72c19a -->","topic":{"id":"c8d06469-2b39-5daa-bda8-b076b7204860","topicId":"c1897d19-8ea9-40e5-84a7-c45a80747a3e","topicName":"Tuberculosis","slug":"tuberculosis","lastRevised":"Last revised in January 2019","chapters":[{"id":"7216c242-e6e9-5726-9bad-d4bbd4071072","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"aa25f749-53e8-5ff7-a3be-ddfd9f824295","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"9c40ce5c-b940-5a6e-a414-cb379ae5f2c1","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"5b948ae0-2789-5df7-b344-42eb6ae4054d","slug":"changes","fullItemName":"Changes"},{"id":"706989f4-45e1-583c-bcbc-d08833e25634","slug":"update","fullItemName":"Update"}]},{"id":"5edbfe3e-e825-5d79-a1d2-fa1b3b258467","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"2e115c8b-8ca5-587b-bf34-83ddeeae2383","slug":"goals","fullItemName":"Goals"},{"id":"dbbfc2a1-e777-55e9-b654-44db5bf1efb4","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"bdce292e-6c5f-53df-a014-fc8432efa249","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"1f5efb77-1619-5cf3-be88-86fd03247324","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"6f93c9e3-2eb5-5d68-bbc0-99b7ea53b835","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"a028a0db-e900-5a0f-88ba-f333bcd824c9","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"24cda0d7-3e0d-58d5-9229-0a15e99013c4","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"c26e051a-e3f8-57b8-95af-985e9e93a3aa","slug":"definition","fullItemName":"Definition"},{"id":"2deaf55e-4677-569a-a2e0-a8748b44829f","slug":"prevalence","fullItemName":"Prevalence"},{"id":"f2d695cb-4d0e-5513-a7f3-01df45726347","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"dc328fb0-65a2-5d6a-94fe-0bfa42962928","slug":"complications","fullItemName":"Complications"},{"id":"72382f51-4bac-5de9-9caf-c6f16082070d","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"7e56c88f-1492-52ab-9f0b-cfc6b986db85","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"b5294e44-2490-5ba7-8d81-0085ae3114a7","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"b90838b4-5d6d-57e8-aabd-afaad5a60e3f","slug":"investigations","fullItemName":"Investigations"},{"id":"8d7ee3e2-c863-574f-a042-172b8d909e84","slug":"screening","fullItemName":"Screening"},{"id":"a6c65c83-026b-50f1-b32d-5d28e8e7ae46","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"880c8c31-e325-5d4b-b4de-6ac05a1a9f94","fullItemName":"Management","slug":"management","subChapters":[{"id":"2ab22745-718a-5096-a75f-2e6c874d6267","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"fd726cd9-2566-5903-9e38-d7333b140c5a","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"3ac0b667-89b4-5934-98e1-938fd35e537f","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"a3834823-1bb2-52a0-92c5-cb04316db808","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"b2e2271f-aaf8-57a5-aba4-42de8a475bc5","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"e611555b-70b5-5ea6-8e53-5220621e1603","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"fdb64832-ab19-58f6-978e-d73fe8657b7d","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"200b04d2-7d10-5430-abe3-3802b135aea7","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"74113d46-a800-5f0b-9d3d-096dc4137936","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"24cda0d7-3e0d-58d5-9229-0a15e99013c4","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}